These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 14923024)
1. A study of the effects of various drugs used in treatment of paralysis agitans. KAPLAN HA; MACHOVER S; BROWDER J; RABINER AM AMA Arch Neurol Psychiatry; 1952 Jun; 67(6):828-9. PubMed ID: 14923024 [No Abstract] [Full Text] [Related]
3. TREATMENT of paralysis agitans. J Am Med Assoc; 1955 Feb; 157(7):597. PubMed ID: 13232986 [No Abstract] [Full Text] [Related]
4. [Experience with disipal (BS 5930) in paralysis agitans]. KOSTER S Geneeskd Gids; 1955 Jul; 33(15):302-8. PubMed ID: 13251449 [No Abstract] [Full Text] [Related]
5. [Thephorin therapy of paralysis agitans]. OTTESEN E Nord Med; 1951 Nov; 46(45):1675-6. PubMed ID: 14899772 [No Abstract] [Full Text] [Related]
6. The psychotherapy of paralysis agitans. DOSHAY LJ J Am Med Assoc; 1960 Mar; 172():1347-51. PubMed ID: 13817741 [No Abstract] [Full Text] [Related]
7. Thirty years of progress in therapy for paralysis agitans (Parkinson's disease). DOSHAY LJ J Am Med Assoc; 1958 Jul; 167(10):1195-7. PubMed ID: 13549243 [No Abstract] [Full Text] [Related]
8. Paralysis agitans treated by surgical thalamolysis (two cases). WATKINS ES Proc R Soc Med; 1960 Nov; 53():975-6. PubMed ID: 13783397 [No Abstract] [Full Text] [Related]
9. Treatment of paralysis agitans with chlorphenoxamine hydrochloride. DOSHAY LJ; CONSTABLE K J Am Med Assoc; 1959 May; 170(1):37-41. PubMed ID: 13640980 [No Abstract] [Full Text] [Related]
10. Use of tolbutamide in paralysis agitans: preliminary report. GATES EW; HYMAN I J Am Med Assoc; 1960 Mar; 172():1351-4. PubMed ID: 13826835 [No Abstract] [Full Text] [Related]
11. Therapeutic exercises in management of paralysis agitans. CLARK EC; CLEMENTS BG; ERICKSON DJ; MACCARTY CS; MULDER DW J Am Med Assoc; 1956 Nov; 162(11):1041-3. PubMed ID: 13366704 [No Abstract] [Full Text] [Related]
13. Prolonged severe hypoglycemia following tolbutamide therapy for paralysis agitans. YONET HM; BALLARD HS N Y State J Med; 1961 Jun; 61():1939-41. PubMed ID: 13787370 [No Abstract] [Full Text] [Related]
14. A study of the effects of various drugs used in the treatment of Parkinsonism. KAPLAN HA; MACHOVER S; BROWDER J; RABINER AM J Nerv Ment Dis; 1953 Feb; 117(2):148-51. PubMed ID: 13061957 [No Abstract] [Full Text] [Related]
15. [Utilization of synergistic and associated movements in the rehabilitation of paralysis]. SIMARRO-PUIG J Rev Clin Esp; 1953 May; 49(4):239-40. PubMed ID: 13089197 [No Abstract] [Full Text] [Related]
16. [Synthetic drugs in the therapy of morbus Parkinson]. LEHOCZKY T Schweiz Med Wochenschr; 1952 Sep; 82(36):904-6. PubMed ID: 12994820 [No Abstract] [Full Text] [Related]
17. Follow-up studies in chemopallidectomy for paralysis agitans. RIKLAN M; DILLER L J Am Med Assoc; 1958 May; 167(1):13-7. PubMed ID: 13538658 [No Abstract] [Full Text] [Related]
18. Clinical observations on the relation of muscular rigidity and tremor in idiopathic paralysis agitans. PARK HW; HAJEK-NICHOLS N South Med J; 1959 Oct; 52():1246-8. PubMed ID: 14430469 [No Abstract] [Full Text] [Related]
19. Treatment of paralysis agitans with orphenadrine (disipal) hydrochloride; results in one hundred seventy-six cases. DOSHAY LJ; CONSTABLE K J Am Med Assoc; 1957 Apr; 163(15):1352-7. PubMed ID: 13415899 [No Abstract] [Full Text] [Related]
20. Five year follow-up of treatment with trihexyphenidyl (artane); outcome in four hundred eleven cases of paralysis agitans. DOSHAY LJ; CONSTABLE K; ZIER A J Am Med Assoc; 1954 Apr; 154(16):1334-6. PubMed ID: 13151847 [No Abstract] [Full Text] [Related] [Next] [New Search]